World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
7467
World Ranking
4629
National Ranking
117

Gregory A. Dekaban publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gregory A. Dekaban sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 188 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gregory A. Dekaban D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gregory A. Dekaban sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gregory A. Dekaban is affiliated with the University of Western Ontario in Canada and has contributed extensively to the field of medicine across several subfields. Their research portfolio includes work in infectious diseases, immunology, biomedical engineering, neurology, and genetics.

The scientist's research focuses heavily on topics related to SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, and the long-term effects of COVID-19. In addition, they have explored traumatic brain injury research, tissue engineering and regenerative medicine, electrospun nanofibers in biomedical applications, and mesenchymal stem cell research.

Gregory A. Dekaban's recent published papers include:

  • Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy (2021, Immunity)
  • Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 (2021, Cell Reports)
  • Repetitive mild traumatic brain injury in mice triggers a slowly developing cascade of long-term and persistent behavioral deficits and pathological changes (2021, Acta Neuropathologica Communications)
  • KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy (2021, bioRxiv (Cold Spring Harbor Laboratory))

The frequent publication venues for this scientist include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Pathogens
  • SSRN Electronic Journal
  • Virologie
  • Cytotherapy

Among frequent coauthors are Jimmy D. Dikeakos, Corby Fink, Jérémie Prévost, Guillaume Beaudoin-Bussières, and Paula J. Foster.

Best Publications

  • The cellular inflammatory response in human spinal cords after injury.

    Jennifer C. Fleming;Michael D. Norenberg;David A. Ramsay;Gregory A. Dekaban

  • Transient Blockade of the CD11d/CD18 Integrin Reduces Secondary Damage after Spinal Cord Injury, Improving Sensory, Autonomic, and Motor Function

    Denis Gris;Daniel R. Marsh;Mark A. Oatway;Yuhua Chen

  • Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury.

    Andrew L. Davies;Keith C. Hayes;Keith C. Hayes;Gregory A. Dekaban;Gregory A. Dekaban

  • Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy.

    Irfan Ullah;Jérémie Prévost;Mark S. Ladinsky;Helen Stone

  • Early anti‐inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats

    Feng Bao;Yuhua Chen;Gregory A. Dekaban;Lynne C. Weaver

  • Inhibition of Monocyte/Macrophage Migration to a Spinal Cord Injury Site by an Antibody to the Integrin αD: A Potential New Anti-inflammatory Treatment

    P.Joy Mabon;Lynne C. Weaver;Gregory A. Dekaban

  • A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment.

    L.R. Saville;C.H. Pospisil;L.A. Mawhinney;F. Bao

  • Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2.

    Romain Gasser;Marc Cloutier;Jérémie Prévost;Corby Fink;Corby Fink

  • RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages

    Fuan Wang;Xiujuan Gao;Xiujuan Gao;John W. Barrett;John W. Barrett;Qing Shao

  • Characterization of Ca2+-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni

    Afzal A. Siddiqui;You Zhou;Ron B. Podesta;Steve R. Karcz

  • Mollaret's meningitis associated with herpes simplex type 2 infection

    François J. Picard;Gregory A. Dekaban;Jaime Silva;George P.A. Rice

  • Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats.

    Feng Bao;Gregory A. Dekaban;Lynne C. Weaver

  • hiv-1 Infection of Human Brain-derived Microvascular Endothelial Cells In Vitro

    S. D. Poland;G. P. A. Rice;G. A. Dekaban

  • Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus.

    J K Ball;H Diggelmann;G A Dekaban;G F Grossi

  • Cytomegalovirus in the Brain: In Vitro Infection of Human Brain-Derived Cells

    Stephen D. Poland;Penny Costello;Gregory A. Dekaban;G. P. A. Rice

  • Anti-CD11d Integrin Antibody Treatment Restores Normal Serotonergic Projections to the Dorsal, Intermediate, and Ventral Horns of the Injured Spinal Cord

    Mark A. Oatway;Yuhua Chen;Jamie C. Bruce;Gregory A. Dekaban

  • Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury.

    Feng Bao;Christopher S. Bailey;Kevin R. Gurr;Stewart I. Bailey

  • CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury.

    Feng Bao;Arthur Brown;Gregory A. Dekaban;Vanessa Omana

  • Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice.

    Leah A. Mawhinney;Sakina G. Thawer;Wei-Yang Lu;Nico van Rooijen

  • An anti‐CD11d integrin antibody reduces cyclooxygenase‐2 expression and protein and DNA oxidation after spinal cord injury in rats

    Feng Bao;Yuhua Chen;Gregory A. Dekaban;Lynne C. Weaver

  • Identification of spinal interneurons antecedent to adrenal sympathetic preganglionic neurons using trans-synaptic transport of herpes simplex virus type 1.

    S. Joshi;M.A. Levatte;G.A. Dekaban;L.C. Weaver

Frequent Co-Authors

Lynne C. Weaver
Lynne C. Weaver University of Western Ontario
Ravi S. Menon
Ravi S. Menon University of Western Ontario
Grant McFadden
Grant McFadden Arizona State University
Robert Bartha
Robert Bartha University of Western Ontario
Andrés Finzi
Andrés Finzi University of Montreal
Jonathan Richard
Jonathan Richard University of Montreal
Joseph S. Gati
Joseph S. Gati University of Western Ontario
Keith A. Crandall
Keith A. Crandall George Washington University
Craig B. Wilen
Craig B. Wilen Yale University
Pamela J. Bjorkman
Pamela J. Bjorkman California Institute of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring complementary online degrees can enhance career prospects in healthcare and research. Many aspiring professionals pursue specialized nursing roles, such as the best psychiatric mental health nurse practitioner programs online, which focus on mental health and offer excellent clinical placement rates. These programs provide vital skills for managing complex patient needs, bridging the gap between immunology and psychiatric care.

Cost is a significant consideration for many learners. Fortunately, options like the cheapest pmhnp programs online make advanced education more accessible without compromising quality. Affordability combined with flexibility helps students balance their studies with professional commitments.

Career advancement often correlates with earning potential. Those holding a Doctor of Nursing Practice (DNP) degree can expect varying salaries across states. Reviewing the dnp salary by location helps candidates plan effectively for their future in healthcare leadership and advanced clinical roles.

For nurses aiming to expand their expertise, pathways like the fnp to acute care np bridge program offer streamlined options to transition between specialties. This flexibility supports lifelong learning and adaptability in a rapidly evolving medical landscape, complementing foundational knowledge gained through immunology studies.

Best Scientists Citing Gregory A. Dekaban

Trending Scientists

Recently Published Articles